Similar articles

• Overview of pharmacological aspects of sedation. Part 2. Combination sedative/analgesics.

  Roelofse J. Roelofse J. SADJ. 2000 Aug;55(8):441-2. SADJ. 2000. PMID: 12608207 No abstract available.
• Propofol for intravenous conscious sedation--an oxymoron.

  Weaver JM. Weaver JM. Anesth Prog. 1999 Summer;46(3):89-90. Anesth Prog. 1999. PMID: 11692347 Free PMC article. No abstract available.
• Intravenous sedation for implant surgery: midazolam, butorphanol, and dexmedetomidine versus midazolam, butorphanol, and propofol.

  Kawaai H, Tomita S, Nakaike Y, Ganzberg S, Yamazaki S. Kawaai H, et al. J Oral Implantol. 2014 Feb;40(1):94-102. doi: 10.1563/AAID-JOI-D-11-00200. Epub 2011 Dec 29. J Oral Implantol. 2014. PMID: 22206410 Clinical Trial.
• Overview of pharmacological aspects of sedation--Part I.

  Roelofse J. Roelofse J. SADJ. 2000 Jul;55(7):387-9. SADJ. 2000. PMID: 12608198 Review. No abstract available.
• Neuroleptanesthesia: current status.

  Bissonnette B, Swan H, Ravussin P, Un V. Bissonnette B, et al. Can J Anaesth. 1999 Feb;46(2):154-68. doi: 10.1007/BF03012550. Can J Anaesth. 1999. PMID: 10083996 Review.